课题基金 / 基金详情

Development of novel therapeutics to inhibit cell proliferation viaPOU6F1 in ovarian clear cell carcinoma

Development of novel therapeutics to inhibit cell proliferation viaPOU6F1 in ovarian clear cell carcinoma
开发通过 POU6F1 抑制卵巢透明细胞癌细胞增殖的新疗法
批准号:
23791857
负责人:
YOSHIOKA Norihito
金额:
$2.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ARID1A, a member of SWI/SNF chromatin remodeling complex, whose members have helices and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. Loss of the ARID1A (a putative tumor suppressor) protein BAF250a has recently been described as a frequent event in ovarian clear cell carcinoma. In this study, we report that restoring wild-type ARID1A expression in ovarian clear cell carcinoma cells that harbor ARID1A mutations is sufficient to suppress cell proliferation and enhance anticancer agent sensitivity. Gene expression analysis identified several down stream targets of ARID1A. Our results provide functional evidence in support of the hypothesis that ARID1A is a bona fide tumor suppressor gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: [鈴木佳克, 松浦綾乃, 山本珠生., 吉岡 範人]
通讯作者: 吉岡 範人
DOI: 10.1111/j.1749-0774.2009.00074.x
发表时间: 2009-11
期刊: Human Cell
影响因子: 4.3
作者: [N. Yoshioka;N. Suzuki;A. Uekawa;K. Kiguchi;B. Ishizuka]
通讯作者: N. Yoshioka;N. Suzuki;A. Uekawa;K. Kiguchi;B. Ishizuka
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Norihito Yoshioka, A.Tozawa-Ono, K.Kiguchi, N.Suzuki]
通讯作者: N.Suzuki
海外基金